💊 Non-Opioid Postsurgical Pain Protocol Simulator

Postoperative Pain Begins At The Incision

Tissue injury ignites four overlapping pain pathways at once.

• 2–6 h: Peak pain onset (after incision closes)
• 0 / 4: Active pathways (none yet blocked)
• ~90%: Typical opioid reliance (in unimodal protocols)
• 8–10: Untreated pain score (on 0–10 scale)

Peripheral inflammation ignites

Damaged cells release prostaglandins that sensitize nearby nerves.

Nerves fire directly

Cut tissue triggers raw nerve-fiber signaling toward the spine.

Four distinct mechanisms drive pain — one drug rarely covers all.

Spinal cord amplifies input

Dorsal horn neurons grow more excitable with repeated signals.

NSAIDs And Acetaminophen Dampen Inflammation

The first non-opioid layer quiets prostaglandin-driven pain signals.

• ~25%: Pain score drop (from baseline severity)
• COX-1/2: Mechanism (inhibition, peripheral + central)
• 30–60 min: Onset time (oral or IV dosing)
• ~25%: Opioid-sparing effect (reduced opioid need)

COX enzymes get blocked

NSAIDs stop prostaglandin synthesis at the injury site.

Acetaminophen adds central action

It dampens pain processing higher up, in the brain and cord.

Combining NSAID plus acetaminophen beats either drug alone.

One pathway now covered

Inflammatory signaling dims, but three pathways remain active.

Local And Regional Anesthesia Blocks Signal Transmission

Nerve blocks and wound infiltration silence local pain conduction.

• ~50%: Pain score drop (cumulative with layer 1)
• NaV block: Mechanism (sodium channel conduction halt)
• 8–24 h: Block duration (single-shot or catheter)
• ~55%: Opioid-sparing effect (cumulative reduction)

Nerve fibers go quiet

Local anesthetic blocks sodium channels along the nerve.

Regional blocks cover wider fields

A single injection numbs an entire surgical region.

Blocking conduction stops pain before it reaches the spine.

Two pathways now covered

Inflammation and local signaling are both dampened.

Adjunct Agents Reach Deeper Pain Circuits

Gabapentinoids and NaV1.8 blockers add complementary pathway coverage.

• ~72%: Pain score drop (cumulative with layers 1–2)
• Ca²⁺ + NaV1.8: Mechanism (channel modulation)
• Dorsal horn: Target (central sensitization site)
• ~80%: Opioid-sparing effect (cumulative reduction)

Gabapentinoids calm the spinal cord

They reduce excitability building up in dorsal horn neurons.

NaV1.8 blockers target nociceptors

A sensory-neuron-specific channel is silenced selectively.

Selective NaV1.8 blockade spares motor and cardiac sodium channels.

Three pathways now covered

Only residual central amplification remains only partly blocked.

Multimodal Non-Opioid Coverage Achieved

Four combined layers deliver comparable relief without opioids.

• ~90%: Pain score drop (all four layers combined)
• 4 / 4: Pathways covered (full mechanistic coverage)
• ~95%: Opioid-sparing effect (near-complete avoidance)
• Optimal: Recovery trajectory (faster mobilization, fewer side effects)

Four mechanisms, one outcome

Each layer blocks a different node in the pain circuit.

Opioid exposure nearly eliminated

Side effects like sedation and ileus drop sharply too.

Stacking non-opioid layers rivals opioid-based analgesia for control.

Recovery accelerates

Patients mobilize sooner with fewer respiratory complications.